Pasar al contenido principal

CARACTERIZACION MOLECULAR Y FUNCIONAL DE NUEVAS CRONOQUINAS QUIMERICAS RECOMBINANTES. IMPLICACIONES EN EL DECLIVE COGNITIVO ASOCIADO A ENVEJECIMIENTO

PID2019-104034RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles

  • Bunuales, María
  • Garduno, Angeles
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
  • Bosch i Merino, Assumpció|||0000-0002-7205-2796
  • GonzÁlez-Aparicio, Manuela
  • Espelosin, Maria
  • García-Gomara, Marta
  • Rico, Alberto J.
  • Garcia-Osta, Ana
  • Cuadrado-Tejedor, Mar
  • Lanciego, Jose L.|||0000-0003-2301-5419
  • Hernandez-Alcoceba, Ruben|||0000-0002-6682-2598
Different screening methods are being developed to generate adeno-associated viral vectors (AAV) with the ability to bypass the blood-brain barrier (BBB) upon intravenous administration. Recently, the AAV9P31 stood out as the most efficient version among a library of peptide-displaying capsids selected in C57BL/6 mice using RNA-driven biopanning. In this work we have characterized in detail its biodistribution in different mouse strains (C57BL/6 and Balb/c), as well as in Sprague Dawley rats and non-human primates (Macaca fascicularis). Using GFP and NanoLuc reporter genes, we confirmed homogeneous infection and transgene expression across the CNS of mice injected intravenously with AAV9P31. A more restricted pattern was observed upon either intracerebroventricular or intraparenchymal injection. Following intravenous delivery, region- and cell-specific differential patterns of transduction were observed in the mouse brain, including a preferential transduction of astrocytes and neurons in the cerebral cortex and striatum, whereas neurons were the only transduced cell type in subcortical locations across the hippocampus, thalamus, hypothalamus, mesencephalon, brainstem and cerebellum. Furthermore, transduced microglial cells were never found in any CNS location. Peripheral organs transduced upon intravenous administration included lung, liver, peritoneum, heart and skeletal muscle. However, a comparable performance of AAV9P31 to bypass the BBB in rats and macaques was not observed, although a more limited neuronal transduction was found in the brainstem of rats upon intravenous delivery. Finally, intracerebroventricular delivery in macaques resulted in neuronal transduction in cortical, subcortical structures and cerebellum following a patchy pattern. In conclusion, the widespread CNS transduction obtained in mice upon intravenous delivery of AAV9P31 represents a powerful tool for modeling a wide variety of neurological disorders as well as an appealing choice for the evaluation of gene therapy-based therapeutics.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

HEBE, A novel chimeric chronokine for ameliorating memory deficits in Alzheimer's disease

  • Esandi Jauregui, Jon|||0000-0001-5529-2686
  • Renault de Barros, Pedro Victor|||0000-0002-5649-3057
  • Capilla López, Maria Dolores|||0000-0002-9483-4887
  • Blanch Garcia, Rebeca|||0000-0001-6726-4084
  • Edo Salvador, Ángel
  • Ramirez-Gómez, David
  • Bosch i Merino, Assumpció|||0000-0002-7205-2796
  • Almolda Ardid, Beatriz|||0000-0001-6631-4385
  • Saura, Carlos Alberto
  • Giraldo, Jesús|||0000-0001-7082-4695
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by amyloid-β and Tau protein depositions, with treatments focusing on single proteins have shown limited success due to the complexity of pathways involved. This study explored the potential of chronokines -proteins that modulate aging-related processes- as an alternative therapeutic approach. Specifically, we focused on a novel pleiotropic chimeric protein named HEBE, combining s-KL, sTREM2 and TIMP2, guided by bioinformatic analyses to ensure the preservation of each protein's conformation, crucial for their functions. In vitro studies confirmed HEBE's stability and enzymatic activities, even suggesting it has different activities compared to the individual chronokines. In vivo experiments on APP/Tau mice revealed improved learning and memory functions with HEBE treatment, along with decreased levels of phosphorylated Tau and minor effects on amyloid-β levels. These findings suggest that HEBE is as a promising therapeutic candidate for ameliorating memory deficits and reducing pTau in an AD mouse model.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles

  • Buñuales, María
  • Garduno, Angeles
  • Chillon, Miguel
  • GONZALEZ-APARICIO, MANUELA
  • Espelosin, Maria
  • Bosch, Assumpció
Characterization of brain; Adeno-associated viral vectors; Expression profiles, Transducció cerebral; Vectores virales adenoasociados; Perfils d'expressió, Transducción cerebral; Vectores virales adenoasociados; Perfiles de expresión, Different screening methods are being developed to generate adeno-associated viral vectors (AAV) with the ability to bypass the blood-brain barrier (BBB) upon intravenous administration. Recently, the AAV9P31 stood out as the most efficient version among a library of peptide-displaying capsids selected in C57BL/6 mice using RNA-driven biopanning. In this work we have characterized in detail its biodistribution in different mouse strains (C57BL/6 and Balb/c), as well as in Sprague Dawley rats and non-human primates (Macaca fascicularis). Using GFP and NanoLuc reporter genes, we confirmed homogeneous infection and transgene expression across the CNS of mice injected intravenously with AAV9P31. A more restricted pattern was observed upon either intracerebroventricular or intraparenchymal injection. Following intravenous delivery, region- and cell-specific differential patterns of transduction were observed in the mouse brain, including a preferential transduction of astrocytes and neurons in the cerebral cortex and striatum, whereas neurons were the only transduced cell type in subcortical locations across the hippocampus, thalamus, hypothalamus, mesencephalon, brainstem and cerebellum. Furthermore, transduced microglial cells were never found in any CNS location. Peripheral organs transduced upon intravenous administration included lung, liver, peritoneum, heart and skeletal muscle. However, a comparable performance of AAV9P31 to bypass the BBB in rats and macaques was not observed, although a more limited neuronal transduction was found in the brainstem of rats upon intravenous delivery. Finally, intracerebroventricular delivery in macaques resulted in neuronal transduction in cortical, subcortical structures and cerebellum following a patchy pattern. In conclusion, the widespread CNS transduction obtained in mice upon intravenous delivery of AAV9P31 represents a powerful tool for modeling a wide variety of neurological disorders as well as an appealing choice for the evaluation of gene therapy-based therapeutics., The authors declare that financial support was received for the research, authorship, and/or publication of this article. Conducted work was funded by MCIN/AEI/10.13039/501100011033/ PID2019-104034RB-I00, PID2020-120308RB, PID2021-128587OB-I00 FEDER, UE, TERAV/ISCIII Next Generation EU-PRTR RD21/0017/0034 and RD21/0017/0008, Generalitat de Catalunya 2021-SGR 00529, Apoyo Dravet Foundation and Desafia Dravet Association. MGA is supported in part by a Pedro Lopez Berastegui grant. AG was supported by CONAHCYT fellowship, Mexico (936633).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

AAV-mediated expression of secreted and transmembrane αKlotho isoforms rescues relevant aging hallmarks in senescent SAMP8 mice

  • Roig-Soriano, Joan|||0000-0002-6134-3141
  • Griñán-Ferré, Christian|||0000-0002-5424-9130
  • Espinosa-Parrilla, J. F.|||0000-0001-6631-3542
  • Abraham, Carmela R|||0000-0002-6649-1960
  • Bosch i Merino, Assumpció|||0000-0002-7205-2796
  • Pallàs, Mercè|||0000-0003-3095-4254
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
Senescence represents a stage in life associated with elevated incidence of morbidity and increased risk of mortality due to the accumulation of molecular alterations and tissue dysfunction, promoting a decrease in the organism's protective systems. Thus, aging presents molecular and biological hallmarks, which include chronic inflammation, epigenetic alterations, neuronal dysfunction, and worsening of physical status. In this context, we explored the AAV9-mediated expression of the two main isoforms of the aging-protective factor Klotho (KL) as a strategy to prevent these general age-related features using the senescence-accelerated mouse prone 8 (SAMP8) model. Both secreted and transmembrane KL isoforms improved cognitive performance, physical state parameters, and different molecular variables associated with aging. Epigenetic landscape was recovered for the analyzed global markers DNA methylation (5-mC), hydroxymethylation (5-hmC), and restoration occurred in the acetylation levels of H3 and H4. Gene expression of pro- and anti-inflammatory mediators in central nervous system such as TNF-α and IL-10, respectively, had improved levels, which were comparable to the senescence-accelerated-mouse resistant 1 (SAMR1) healthy control. Additionally, this improvement in neuroinflammation was supported by changes in the histological markers Iba1, GFAP, and SA β-gal. Furthermore, bone tissue structural variables, especially altered during senescence, recovered in SAMP8 mice to SAMR1 control values after treatment with both KL isoforms. This work presents evidence of the beneficial pleiotropic role of Klotho as an anti-aging therapy as well as new specific functions of the KL isoforms for the epigenetic regulation and aged bone structure alteration in an aging mouse model. Intraventricular administration of AAV vectors expressing secreted and transmembrane Klotho isoforms, rescued accelerated aging phenotype of SAMP8 mice. An improvement in cognitive and physical performance, recovery of epigenetic, inflammatory and senescence markers, as well as structural changes in long bones of these mice was detected.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy

  • Rubinstein, Tammi Arbel|||0000-0001-8858-5194
  • Reuveni, Inbal
  • Hesin, Arkadi
  • Klein-Goldberg, Anat
  • Olauson, Hannes
  • Larsson, Tobias E.
  • Abraham, Carmela R.|||0000-0002-6649-1960
  • Zeldich, Ella
  • Bosch i Merino, Assumpció|||0000-0002-7205-2796
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
  • Hollander, Kenneth Samuel
  • Shabtay-Orbach, Ayelet
  • Vainer, Gilad W.
  • Wolf, Ido
  • Rubinek, Tami
Klotho is an anti-aging transmembrane protein, which can be shed and can function as a hormone. Accumulating data indicate that klotho is a tumor suppressor in a wide array of malignancies, and designate the subdomain KL1 as the active region of the protein towards this activity. We aimed to study the role of klotho as a tumor suppressor in pancreatic ductal adenocarcinoma (PDAC). Bioinformatics analyses of The Cancer Genome Atlas (TCGA) datasets revealed a correlation between the survival of PDAC patients, levels of klotho expression, and DNA methylation, and demonstrated a unique hypermethylation pattern of klotho in pancreatic tumors. The in vivo effects of klotho and KL1 were examined using three mouse models. Employing a novel genetic model, combining pancreatic klotho knockdown with a mutation in Kras, the lack of klotho contributed to PDAC generation and decreased mousece survival. In a xenograft model, administration of viral particles carrying sKL, a spliced klotho isoform containing the KL1 domain, inhibited pancreatic tumors. Lastly, treatment with soluble sKL prolonged survival of Pdx1-Cre; KrasG12D/+;Trp53R172H/+ (KPC) mice, a model known to recapitulate human PDAC. In conclusion, this study provides evidence that klotho is a tumor suppressor in PDAC. Furthermore, these data suggest that the levels of klotho expression and DNA methylation could have prognostic value in PDAC patients, and that administration of exogenous sKL may serve as a novel therapeutic strategy to treat PDAC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Differential toxicity profile of secreted and processed α-Klotho expression over mineral metabolism and bone microstructure

  • Roig-Soriano, Joan|||0000-0002-6134-3141
  • Sánchez-de-Diego, Cristina|||0000-0002-0905-1213
  • Esandi Jauregui, Jon|||0000-0001-5529-2686
  • Verdés, Sergi|||0000-0002-4266-5380
  • Abraham, Carmela R|||0000-0002-6649-1960
  • Bosch i Merino, Assumpció|||0000-0002-7205-2796
  • Ventura, Francesc|||0000-0001-9673-9405
  • Chillón Rodríguez, Miguel|||0000-0003-0840-2111
The aging-protective gene α-Klotho (KL) produces two main transcripts. The full-length mRNA generates a transmembrane protein that after proteolytic ectodomain shedding can be detected in serum as processed Klotho (p-KL), and a shorter transcript which codes for a putatively secreted protein (s-KL). Both isoforms exhibit potent pleiotropic beneficial properties, although previous reports showed negative side effects on mineral homeostasis after increasing p-KL concentration exogenously. Here, we expressed independently both isoforms using gene transfer vectors, to assess s-KL effects on mineral metabolism. While mice treated with p-KL presented altered expression of several kidney ion channels, as well as altered levels of P and Ca 2+ in blood, s-KL treated mice had levels comparable to Null-treated control mice. Besides, bone gene expression of Fgf23 showed a fourfold increase after p-KL treatment, effects not observed with the s-KL isoform. Similarly, bone microstructure parameters of p-KL-treated mice were significantly worse than in control animals, while this was not observed for s-KL, which showed an unexpected increase in trabecular thickness and cortical mineral density. As a conclusion, s-KL (but not p-KL) is a safe therapeutic strategy to exploit KL anti-aging protective effects, presenting no apparent negative effects over mineral metabolism and bone microstructure.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles

  • Buñuales, María
  • Garduno, Angeles
  • Chillon, Miguel
  • GONZALEZ-APARICIO, MANUELA
  • Espelosin, Maria
  • Bosch, Assumpció
Characterization of brain; Adeno-associated viral vectors; Expression profiles, Transducció cerebral; Vectores virales adenoasociados; Perfils d'expressió, Transducción cerebral; Vectores virales adenoasociados; Perfiles de expresión, Different screening methods are being developed to generate adeno-associated viral vectors (AAV) with the ability to bypass the blood-brain barrier (BBB) upon intravenous administration. Recently, the AAV9P31 stood out as the most efficient version among a library of peptide-displaying capsids selected in C57BL/6 mice using RNA-driven biopanning. In this work we have characterized in detail its biodistribution in different mouse strains (C57BL/6 and Balb/c), as well as in Sprague Dawley rats and non-human primates (Macaca fascicularis). Using GFP and NanoLuc reporter genes, we confirmed homogeneous infection and transgene expression across the CNS of mice injected intravenously with AAV9P31. A more restricted pattern was observed upon either intracerebroventricular or intraparenchymal injection. Following intravenous delivery, region- and cell-specific differential patterns of transduction were observed in the mouse brain, including a preferential transduction of astrocytes and neurons in the cerebral cortex and striatum, whereas neurons were the only transduced cell type in subcortical locations across the hippocampus, thalamus, hypothalamus, mesencephalon, brainstem and cerebellum. Furthermore, transduced microglial cells were never found in any CNS location. Peripheral organs transduced upon intravenous administration included lung, liver, peritoneum, heart and skeletal muscle. However, a comparable performance of AAV9P31 to bypass the BBB in rats and macaques was not observed, although a more limited neuronal transduction was found in the brainstem of rats upon intravenous delivery. Finally, intracerebroventricular delivery in macaques resulted in neuronal transduction in cortical, subcortical structures and cerebellum following a patchy pattern. In conclusion, the widespread CNS transduction obtained in mice upon intravenous delivery of AAV9P31 represents a powerful tool for modeling a wide variety of neurological disorders as well as an appealing choice for the evaluation of gene therapy-based therapeutics., The authors declare that financial support was received for the research, authorship, and/or publication of this article. Conducted work was funded by MCIN/AEI/10.13039/501100011033/ PID2019-104034RB-I00, PID2020-120308RB, PID2021-128587OB-I00 FEDER, UE, TERAV/ISCIII Next Generation EU-PRTR RD21/0017/0034 and RD21/0017/0008, Generalitat de Catalunya 2021-SGR 00529, Apoyo Dravet Foundation and Desafia Dravet Association. MGA is supported in part by a Pedro Lopez Berastegui grant. AG was supported by CONAHCYT fellowship, Mexico (936633).